Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.

Durect Corp

DRRX
0,88
-0,0325 (-3,56%)
29 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
29/11/202420:30EDGAR2Form 8-K/A - Current report: [Amend]
25/11/202415:05EDGAR2Form 8-K - Current report
25/11/202412:00PRNUSDURECT Corporation Announces Sale of ALZET® Product Line to..
14/11/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/11/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202422:15EDGAR2Form 8-K - Current report
17/10/202414:30PRNUSDURECT Corporation to Present Data on Larsucosterol at The..
16/10/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/10/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/9/202422:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/9/202417:24EDGAR2Form 8-K/A - Current report: [Amend]
25/9/202415:00EDGAR2Form 8-K - Current report
25/9/202414:00PRNUSDURECT Corporation Announces Phase 3 Registrational Trial..
11/9/202418:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202422:30PRNUSDURECT Corporation to Present at the H.C. Wainwright Global..
26/8/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
14/8/202423:01EDGAR2Form S-3 - Registration statement under Securities Act of..
13/8/202422:15EDGAR2Form 8-K - Current report
12/8/202422:10EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/8/202422:05EDGAR2Form DEF 14A - Other definitive proxy statements
06/8/202419:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202422:30EDGAR2Form PRE 14A - Other preliminary proxy statements
30/7/202422:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:30EDGAR2Form 8-K - Current report
21/5/202422:35EDGAR2Form 8-K - Current report
21/5/202414:00PRNUSDURECT Corporation Receives FDA Breakthrough Therapy..
14/5/202422:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/5/202422:17EDGAR2Form 8-K - Current report
13/5/202422:05PRNUSDURECT Corporation Reports First Quarter 2024 Financial..
07/5/202422:30PRNUSDURECT Corporation to Announce First Quarter 2024 Financial..
30/4/202413:00PRNUSDURECT Corporation Announces Late-Breaking Oral Presentation..
27/3/202421:01PRNUSDURECT Corporation Reports Fourth Quarter and Full Year 2023..
20/3/202421:30PRNUSDURECT Corporation to Announce Fourth Quarter and Full Year..
04/3/202417:37EDGAR2Form 8-K - Current report
04/3/202413:00PRNUSDURECT and Charles River Laboratories Enter into..
14/2/202422:16EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202400:48PRNUSDURECT Corporation to Present at the Oppenheimer 34th Annual..
22/12/202322:15EDGAR2Form 8-K - Current report
01/12/202322:28EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
Apertura: 0,9325 Min: 0,852455 Max: 0,94
Chiusura: 0,9125

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network